Case study

Bringing together technical and strategic expertise to represent the full value of an innovative product in an underserved area

Health Economics & Evidence Synthesis
Pascale Dequen-O'Byrne, Kerrie Ford
January 1, 2024
•
1
min read

Snapshot

At a glance

A global pharmaceutical company partnered with us to provide them a suite of market access activities to realise the full potential of a product with a novel mechanism of action

Client

A global healthcare company

Challenge

The client required coordinated support to navigate a complex market access landscape and build a compelling value story for key stakeholders.

Support

We combined strategic market access insight, evidence generation planning, and health economic and value communication expertise, to create a cohesive approach that strengthened decision-making and supported successful engagement throughout the access journey.

Outcome

Our client's product was recommended for reimbursement, with the materials developed used across multiple markets.

The challenge

Existing approach not capturing the product's full value story.

The product had a unique mechanism of action that suggested potential benefits that were only partially captured in the clinical trials, risking the full value of the asset not being realised.

Our approach

Collaborative, integrated market access support for better access readiness.

We worked as an extension of the client's team, combining strategic insight with technical expertise to provide coordinated support. By bringing together specialists from multiple disciplines, we developed a comprehensive market access package that reflected the full value story of the product. We provided evidence generation planning, economic modelling, and value messaging, to support reimbursement and post-launch access.

  • We developed a new economic model structure to capture and emphasise the product's unique value story
  • Real-world evidence was collected and analysed to map current treatment practice and costs
  • We organised and led an advisory board of HTA and clinical experts to validate the model and assess the potential value messages
  • We developed a value story and incorporated new value elements into the global value dossier and other resources
  • We designed a short survey to provide local input into how the product would improve treatment practice

The outcome

A partnership throughout the market access journey

Our client gained access to the expertise they needed to address market access challenges from multiple perspectives. The resulting strategy provided greater clarity, stronger alignment across evidence and commercial objectives, and increased confidence engaging with key stakeholders.

No items found.

Don't just take our word for it

“Newmarket’s top strengths are their connections with senior levels of the NHS and government, and their pragmatic, strategic advisory services—grounded in their experience of what works and what doesn’t in policy-making.”

Policy & Public Affairs Client
Surgical robotics company

“The people are excellent, and the relationship is fantastic. They are always available to support and keep themselves updated on everything happening in the market. Their unique proposition is their overarching understanding of the UK market.”

Market Intelligence Client
Industry client

“Newmarket’s strength is intelligence of what’s going on in the NHS—both from policy and the reality of what’s happening on the ground.”

Health System Client
Healthcare services provider

Related case studies

Continue reading

Health Economics & Evidence Synthesis
1
min read

Bringing together technical and strategic expertise to represent the full value of an innovative product in an underserved area

A global pharmaceutical company partnered with us to provide them a suite of market access activities to realise the full potential of a product with a novel mechanism of action

13 September 2026
Health Economics & Evidence Synthesis
1
min read

Bringing together technical and strategic expertise to represent the full value of an innovative product in an underserved area

A global pharmaceutical company partnered with us to provide them a suite of market access activities to realise the full potential of a product with a novel mechanism of action

September 13, 2026